These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17898235)

  • 1. A new approach to idiopathic nephrotic syndrome.
    Kausman JY; Kitching AR
    J Am Soc Nephrol; 2007 Oct; 18(10):2621-2. PubMed ID: 17898235
    [No Abstract]   [Full Text] [Related]  

  • 2. A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells.
    Sellier-Leclerc AL; Duval A; Riveron S; Macher MA; Deschenes G; Loirat C; Verpont MC; Peuchmaur M; Ronco P; Monteiro RC; Haddad E
    J Am Soc Nephrol; 2007 Oct; 18(10):2732-9. PubMed ID: 17855645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic nephrotic syndrome].
    Belovezhdov N
    Vutr Boles; 1984; 23(4):14-21. PubMed ID: 6390968
    [No Abstract]   [Full Text] [Related]  

  • 4. [The study of T and B lymphocytes in glomerulopathy with minimal lesions].
    Sasdelli M; Cagnoli L; Rovinetti C; Beltrandi E; Catizone L; Zucchelli P
    Minerva Nefrol; 1979; 26(2):145-9. PubMed ID: 314073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Class II human leukocyte antigens in minimal change nephrotic syndrome and focal segmental glomerulosclerosis--preliminary study].
    Krasowska-KwiecieĊ„ A; Sancewicz-Pach K; Pogan A
    Pol Merkur Lekarski; 2001 Apr; 10(58):256-8. PubMed ID: 11434170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunodynamics of minimal change nephrotic syndrome in adults].
    Yokoyama H
    Nihon Jinzo Gakkai Shi; 1984 Jan; 26(1):1-10. PubMed ID: 6737777
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Cho MH; Hong EH; Lee TH; Ko CW
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of idiopathic nephrotic syndrome.
    Zhang SY; Audard V; Fan Q; Pawlak A; Lang P; Sahali D
    Contrib Nephrol; 2011; 169():94-106. PubMed ID: 21252513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome.
    Herrod HG; Stapleton FB; Trouy RL; Roy S
    Clin Exp Immunol; 1983 Jun; 52(3):581-5. PubMed ID: 6603300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of mesangial IgM nephropathy into focal segmental glomerulosclerosis.
    Jennette JC
    Am J Nephrol; 1981; 1(3-4):222. PubMed ID: 7349055
    [No Abstract]   [Full Text] [Related]  

  • 11. Minimal Change Disease and FSGS Are a Spectrum of a Single Disease within Immune-Mediated Nephrotic Syndrome.
    Sim JJ; Smoyer WE; Schachter AD
    Kidney360; 2024 Aug; 5(8):1197-1199. PubMed ID: 38980731
    [No Abstract]   [Full Text] [Related]  

  • 12. [The significance of predominant IgM deposition in glomerular diseases].
    Koshino Y; Kida H; Yokoyama H; Yoshimura M; Asamoto T; Saito Y; Tomosugi N; Abe T; Hattori N
    Nihon Jinzo Gakkai Shi; 1984 Oct; 26(10):1293-300. PubMed ID: 6527428
    [No Abstract]   [Full Text] [Related]  

  • 13. [The immunosuppressive therapy of chronic (Bright's) nephritis].
    Krasnova TN; Shilov EM
    Ter Arkh; 1993; 65(6):88-93. PubMed ID: 8378860
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoantibodies Targeting Nephrin in Podocytopathies.
    Bruschi M; Angeletti A; Ghiggeri GM
    N Engl J Med; 2024 Oct; 391(14):1366. PubMed ID: 39383469
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies Targeting Nephrin in Podocytopathies.
    Gleeson PJ; Monteiro RC
    N Engl J Med; 2024 Oct; 391(14):1365. PubMed ID: 39383467
    [No Abstract]   [Full Text] [Related]  

  • 16. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).
    Gigante M; Pontrelli P; Montemurno E; Roca L; Aucella F; Penza R; Caridi G; Ranieri E; Ghiggeri GM; Gesualdo L
    Nephrol Dial Transplant; 2009 Jun; 24(6):1858-64. PubMed ID: 19131354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies Targeting Nephrin in Podocytopathies.
    Berg AH; Karumanchi SA
    N Engl J Med; 2024 Oct; 391(14):1365-1366. PubMed ID: 39383468
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric nephrotic syndrome: from the simple to the complex.
    Lane JC; Kaskel FJ
    Semin Nephrol; 2009 Jul; 29(4):389-98. PubMed ID: 19615560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP; van de Kar NC; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levamisole on T cell in minimal change nephrotic syndrome.
    Dayal R; Prasad R; Mathur P; Sharma R; Elhence BR; Singh K
    Indian Pediatr; 1988 Dec; 25(12):1184-7. PubMed ID: 3266962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.